Table 4.

The levels of circulatory inflammatory biomarkers in various combinations of the three studied features.

Features	CRP (mg/dL)	IL-6 (pg/mL)	TNF-α (pg/mL)
Normal to moderate OSAS, male and non-obese (n = 17)	0.142 ± 0.253	0.681 ± 0.259	0.915 ± 0.354
Normal to moderate OSAS, male and obese (n = 22)	0.224 ± 0.236	1.243 ± 0.676	1.238 ± 0.408
Normal to moderate OSAS, female and non-obese (n = 15)	0.182 ± 0.409	1.099 ± 0.638	1.237 ± 0.451
Normal to moderate OSAS, female and obese (n = 9)	0.467 ± 0.294	2.358 ± 0.801	1.166 ± 0.356
Severe OSAS, male and non-obese (n = 12)	0.152 ± 0.214	1.098 ± 0.553	1.308 ± 0.476
Severe OSAS, male and obese (n = 10)	0.430 ± 0.276	2.526 ± 1.684	0.967 ± 0.336
Severe OSAS, female and non-obese (n = 6)	0.191 ± 0.227	1.280 ± 0.920	1.307 ± 0.321
Severe OSAS, female and obese (n = 9)	0.483 ± 0.574	2.226 ± 1.377	1.196 ± 0.494

Abbreviations: CRP, C-reactive protein; IL-6, interleukin-6; OSAS, obstructive sleep apnea syndrome; TNF-α, tumor necrosis factor-α.